Current and emerging treatments for the management of myasthenia gravis

Myasthenia gravis is an autoimmune neuromuscular disorder. There are several treatment options, including symptomatic treatment (acetylcholinesterase inhibitors), short-term immunosuppression (corticosteroids), long-term immunosuppression (azathioprine, cyclosporine, cyclophosphamide, methotrexate,...

Descripción completa

Detalles Bibliográficos
Autor principal: Sathasivam, Sivakumar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2011
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150477/
https://www.ncbi.nlm.nih.gov/pubmed/21845054
http://dx.doi.org/10.2147/TCRM.S14015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3150477/
https://www.ncbi.nlm.nih.gov/pubmed/21845054
http://dx.doi.org/10.2147/TCRM.S14015

Ejemplares similares